Cercar

01/06/2024 Quality assurance of add-on testing in plasma samples: stability limit for 29 biochemical analytes
Illana, FJ, García-Osuna, A, Sospedra, M, Ferrer, R, Martínez-Brú, C, Guiñón, L. Quality assurance of add-on testing in plasma samples: stability limit for 29 biochemical analytes. Biochemia Medica. 2024; 34(2)DOI:10.11613/BM.2024.020704. PMID:38665870. IF:1.800(Q3/6D).
01/06/2024 Inhibitory effects of LRP1-based immunotherapy on cardiac extracellular matrix biophysical alterations induced by hypercholesterolemia
Lhoëst, MTL, Samouillan, V, García, E, Amaro, AB, Dandurand, J, Dato, VA, Guerra, JM, Escolà-Gil, JC, Chiabrando, G, Enrich, C. Inhibitory effects of LRP1-based immunotherapy on cardiac extracellular matrix biophysical alterations induced by hypercholesterolemia. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
29/05/2024 Decreased atherosclerosis and abdominal aortic aneurysm in mice deficient in polymeric immunoglobulin receptor
Pardo, IC, Botija, BP, Garcia, AG, Villanueva, LO, Folgado, IM, Raposo,, Mur, S, Robles,, Gil, JCE, Nunez, E, Sancho, D, Vazquez, J, Colio, LMB, Ramiro, A, Ventura, JLM. Decreased atherosclerosis and abdominal aortic aneurysm in mice deficient in polymeric immunoglobulin receptor. CARDIOVASCULAR RESEARCH. 2024; 120DOI:10.1093/cvr/cvae088.161. PMID:. IF:13.300(Q1/1D).
29/05/2024 Role of polymeric immunoglobulin receptor in glucose metabolism
Botija, MP, Pardo, IC, Garcia, AG, Villanueva, LO, Colio, LB, Ramiro, A, Gil, JCE, Ventura, JLM. Role of polymeric immunoglobulin receptor in glucose metabolism. CARDIOVASCULAR RESEARCH. 2024; 120DOI:10.1093/cvr/cvae088.192. PMID:. IF:13.300(Q1/1D).
01/01/2024 Hydroxytyrosol Induces Dyslipidemia in an ApoB100 Humanized Mouse Model
de las Hazas, MCL, del Saz-Lara, A, Cedó, L, Crespo, MC, Tomé-Carneiro, J, Chapado, LA, Macià, A, Visioli, F, Escola-Gil, JC, Dávalos, A. Hydroxytyrosol Induces Dyslipidemia in an ApoB100 Humanized Mouse Model. MOLECULAR NUTRITION & FOOD RESEARCH. 2024; 68(1)DOI:10.1002/mnfr.202300508. PMID:37933702. IF:4.200(Q1/3D).
14/12/2023 Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulation
Martinez-Campanario, MC, Cortés, M, Moreno-Lanceta, A, Han, L, Ninfali, C, Domínguez, V, Andrés-Manzano, MJ, Farràs, M, Esteve-Codina, A, Enrich, C, Diaz-Crespo, FJ, Pintado, B, Escolà-Gil, JC, de Frutos, PG, Andrés, V, Melgar-Lesmes, P, Postigo, A. Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulation. Nature Communications. 2023; 14(1)DOI:10.1038/s41467-023-43896-7. PMID:38097578. IF:14.700(Q1/1D).
01/11/2023 Characterization of add-on testing before and after automation at a core laboratory
García-Osuna, A, Muñoz, LG, Pallaruelo, MC, Usero, AM, Eduardo, BC, Ramos, JL, Canyelles, M, Brú, CM, Cámara, FJI. Characterization of add-on testing before and after automation at a core laboratory. Heliyon. 2023; 9(11)DOI:10.1016/j.heliyon.2023.e22096. PMID:38034602. IF:3.400(Q1/3D).
27/10/2023 Systems biology and data-driven machine learning-based models in personalized cardiovascular medicine
Hueso, M, Rotllan, N, Escolà-Gil, JC, Vellido, A. Systems biology and data-driven machine learning-based models in personalized cardiovascular medicine. Frontiers in Cardiovascular Medicine. 2023; 10DOI:10.3389/fcvm.2023.1320110. PMID:37965080. IF:2.800(Q2/4D).